Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Wild-type versus mutant MMP-8 in melanoma: 'when you come to a fork in the road, take it'.

Blackburn JS, Brinckerhoff CE.

Pigment Cell Melanoma Res. 2009 Jun;22(3):248-50. doi: 10.1111/j.1755-148X.2009.00573.x. Epub 2009 Apr 15. No abstract available.

PMID:
19397759
2.

Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma.

Palavalli LH, Prickett TD, Wunderlich JR, Wei X, Burrell AS, Porter-Gill P, Davis S, Wang C, Cronin JC, Agrawal NS, Lin JC, Westbroek W, Hoogstraten-Miller S, Molinolo AA, Fetsch P, Filie AC, O'Connell MP, Banister CE, Howard JD, Buckhaults P, Weeraratna AT, Brody LC, Rosenberg SA, Samuels Y.

Nat Genet. 2009 May;41(5):518-20. doi: 10.1038/ng.340. Epub 2009 Mar 29.

3.

Driving in the melanoma landscape.

Herlyn M.

Exp Dermatol. 2009 Jun;18(6):506-8. doi: 10.1111/j.1600-0625.2009.00872.x. Epub 2009 Mar 29.

PMID:
19366372
4.

Matrix metalloproteinase-8 and the regulation of blood pressure, vascular inflammation, and atherosclerotic lesion growth.

Mallat Z.

Circ Res. 2009 Oct 23;105(9):827-9. doi: 10.1161/CIRCRESAHA.109.208595. No abstract available.

5.

De-N-acetyl GM3 promotes melanoma cell migration and invasion through urokinase plasminogen activator receptor signaling-dependent MMP-2 activation.

Liu JW, Sun P, Yan Q, Paller AS, Gerami P, Ho N, Vashi N, Le Poole IC, Wang XQ.

Cancer Res. 2009 Nov 15;69(22):8662-9. doi: 10.1158/0008-5472.CAN-09-1099. Epub 2009 Nov 10.

6.

High throughput analysis of proteins associating with a proinvasive MT1-MMP in human malignant melanoma A375 cells.

Tomari T, Koshikawa N, Uematsu T, Shinkawa T, Hoshino D, Egawa N, Isobe T, Seiki M.

Cancer Sci. 2009 Jul;100(7):1284-90. doi: 10.1111/j.1349-7006.2009.01173.x. Epub 2009 Apr 21.

7.

Healing of extraction sockets in collagenase-2 (matrix metalloproteinase-8)-deficient mice.

Korpi JT, Aström P, Lehtonen N, Tjäderhane L, Kallio-Pulkkinen S, Siponen M, Sorsa T, Pirilä E, Salo T.

Eur J Oral Sci. 2009 Jun;117(3):248-54. doi: 10.1111/j.1600-0722.2009.00620.x.

PMID:
19583751
8.

Melanocortin 1 receptor mutations impact differentially on signalling to the cAMP and the ERK mitogen-activated protein kinase pathways.

Herraiz C, Jiménez-Cervantes C, Zanna P, García-Borrón JC.

FEBS Lett. 2009 Oct 6;583(19):3269-74. doi: 10.1016/j.febslet.2009.09.023. Epub 2009 Sep 13.

9.

Matrix metalloproteinase-9 expression in desmoplastic melanoma.

Hoashi T, Kikuchi K, Watanabe S, Nanko H, Tamaki K.

J Dermatol. 2008 Feb;35(2):122-3. doi: 10.1111/j.1346-8138.2008.00427.x. No abstract available.

PMID:
18271811
10.

A cut above the rest? MMP-8 and liver fibrosis gene therapy.

Iredale JP.

Gastroenterology. 2004 Apr;126(4):1199-201. Review. No abstract available.

PMID:
15057760
11.

Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells.

Besch R, Poeck H, Hohenauer T, Senft D, Häcker G, Berking C, Hornung V, Endres S, Ruzicka T, Rothenfusser S, Hartmann G.

J Clin Invest. 2009 Aug;119(8):2399-411. doi: 10.1172/JCI37155. Epub 2009 Jul 20.

12.

Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms.

Sanada M, Suzuki T, Shih LY, Otsu M, Kato M, Yamazaki S, Tamura A, Honda H, Sakata-Yanagimoto M, Kumano K, Oda H, Yamagata T, Takita J, Gotoh N, Nakazaki K, Kawamata N, Onodera M, Nobuyoshi M, Hayashi Y, Harada H, Kurokawa M, Chiba S, Mori H, Ozawa K, Omine M, Hirai H, Nakauchi H, Koeffler HP, Ogawa S.

Nature. 2009 Aug 13;460(7257):904-8. doi: 10.1038/nature08240. Epub 2009 Jul 20.

PMID:
19620960
13.

Circulating matrix metalloproteinase-8 (MMP-8) and MMP-9 are increased in chronic periodontal disease and decrease after non-surgical periodontal therapy.

Marcaccini AM, Novaes AB Jr, Meschiari CA, Souza SL, Palioto DB, Sorgi CA, Faccioli LH, Tanus-Santos JE, Gerlach RF.

Clin Chim Acta. 2009 Nov;409(1-2):117-22. doi: 10.1016/j.cca.2009.09.012. Epub 2009 Sep 12.

PMID:
19751716
14.

Role of Wnt-5A in interleukin-1beta-induced matrix metalloproteinase expression in rabbit temporomandibular joint condylar chondrocytes.

Ge X, Ma X, Meng J, Zhang C, Ma K, Zhou C.

Arthritis Rheum. 2009 Sep;60(9):2714-22. doi: 10.1002/art.24779.

15.

Control of melanoma invasiveness by anticollagenolytic agents: a reappraisal of an old concept.

Bourguet E, Sapi J, Emonard H, Hornebeck W.

Anticancer Agents Med Chem. 2009 Jun;9(5):576-9.

PMID:
19519299
16.

Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.

Park SK, Hwang YS, Park KK, Park HJ, Seo JY, Chung WY.

Carcinogenesis. 2009 Jul;30(7):1225-33. doi: 10.1093/carcin/bgp111. Epub 2009 May 6.

17.

Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells.

Huang PH, Chen YH, Wang CH, Chen JS, Tsai HY, Lin FY, Lo WY, Wu TC, Sata M, Chen JW, Lin SJ.

Arterioscler Thromb Vasc Biol. 2009 Aug;29(8):1179-84. doi: 10.1161/ATVBAHA.109.189175. Epub 2009 May 21.

18.

Epidermal growth factor receptor regulates MT1-MMP and MMP-2 synthesis in SiHa cells via both PI3-K/AKT and MAPK/ERK pathways.

Zhang Z, Song T, Jin Y, Pan J, Zhang L, Wang L, Li P.

Int J Gynecol Cancer. 2009 Aug;19(6):998-1003. doi: 10.1111/IGC.0b013e3181a83749.

PMID:
19820359
19.

Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts.

Smith PC, Guerrero J, Tobar N, Cáceres M, González MJ, Martínez J.

J Periodontal Res. 2009 Feb;44(1):73-80. doi: 10.1111/j.1600-0765.2007.01081.x.

PMID:
19515020
20.

Mouse pigmentation mutants help identify a uveal melanoma oncogene.

Hayward NK.

Pigment Cell Melanoma Res. 2009 Feb;22(1):2-3. doi: 10.1111/j.1755-148X.2008.00531.x. Epub 2008 Dec 16. No abstract available.

PMID:
19140886
Items per page

Supplemental Content

Write to the Help Desk